Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Hansheng Zhou Insider Profile
4 Followers
Hansheng Zhou, Director at Cellular Biomedicine Group, holds 2.27M shares in Cellular Biomedicine Group (Ticker: CBMG).
Hansheng Zhou Cellular Biomedicine Group (CBMG)Director
Cellular Biomedicine Group (CBMG)
Director
Not Ranked
Hansheng Zhou has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Hansheng Zhou does not currently own shares as a corporate insider.
A breakdown of Hansheng Zhou's holdings
Insider Roles
Hansheng Zhou does not currently hold a role as a corporate insider.
Roles that Hansheng Zhou holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Hansheng Zhou
Hansheng Zhou's Trading History
List of latest transactions for each holding click on a transaction to see Hansheng Zhou's performance on stock
You May Also Like
Hansheng Zhou insider profile FAQ
What is the percentage of profitable transactions made by Hansheng Zhou?
The percentage of profitable transactions made by Hansheng Zhou is ―.
What is the average return per transaction made by Hansheng Zhou?
The average return per transaction made by Hansheng Zhou is ―.
What stocks does Hansheng Zhou hold?
Hansheng Zhou holds: CBMG stocks.
What was Hansheng Zhou’s latest transaction?
Hansheng Zhou latest transaction was an Uninformative Buy of ―.
What was Hansheng Zhou's most profitable transaction?
Hansheng Zhou’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Hansheng Zhou's role in Cellular Biomedicine Group?
Hansheng Zhou's role in Cellular Biomedicine Group is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.